Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the ...
The US accounts for nearly a third of India’s pharmaceutical exports, mainly cheaper versions of popular drugs, with sales ...
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
Eli Lilly is making a bold move with its experimental weight-loss pill, orforglipron, by recording nearly $550 million in ...
WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...
My husband has been diagnosed with dyslexia and dyspraxia, and plausibly self-diagnosed with restless leg syndrome and ADHD.
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results